NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)-- #tech--Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, announced today that it will participate in the 20th Annual Needham Technology, Media & Consumer 1x1 Conference on May 13th in New York, and in the Oppenheimer 26th Annual Israeli Conference on May 18th in Israel. Tal Jacobson, CEO, and Elad Tzubey, CFO will host one-on-one meetings with investors. To schedule a meetin.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6-C™ and M6-L™ artificial disc product.

CHICAGO--(BUSINESS WIRE)--ADM (NYSE: ADM) today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Net earnings of $295 million, adjusted net earnings1 of $338 million Earnings per share2 of $0.61, with adjusted EPS1,2 of $0.70, both down versus the prior year quarter Trailing four-quarter average return on invested capital (ROIC) of 5.4%, trailing four-quarter average adjusted ROIC1 of 7.0% Cash flows used in operating activities were $(342) mi.

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the first quarter ended March 31, 2025. “We continue to execute across the portfolio as we work towards submitting the veligrotug BLA in the second half of 2025, advancing our VRDN-003 subcutaneous clinical tri.

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients. All patients experienced stabilization of Expanded Disability Status Scale (EDSS) scores.

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Dream Finders Homes, Inc. (the “Company”, “Dream Finders Homes”, “Dream Finders” or “DFH”) (NYSE: DFH) announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights (As Compared to First Quarter 2024) Homebuilding revenues increased 18% to $970 million from $825 million Home closings increased 16% to 1,925 from 1,655 Net new orders increased 18% to 2,032 from 1,724 Homebuilding gross margin of 19.2% compared to 17.

CHICAGO--(BUSINESS WIRE)--Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today introduced the Morningstar Medalist Rating™ for Semiliquid Funds, expanding its established Medalist Rating framework to the growing segment of semiliquid investment vehicles. As public and private markets converge and product offerings become more complex, the new rating brings greater transparency and due diligence to private markets. "Semiliquid funds are becoming more acc.

TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global energy and compute infrastructure company, today announced its participation in several upcoming investor and industry conferences.

TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce that McEwen Mining (“MUX”) has exercised 9,200,000 common share purchase warrants as part of the early warrant exercise incentive program for gross proceeds of $828,000. Proceeds from the warrant exercise will be used to advance the Company's 2025 bulk sampling program at its 100%-owned Pardo Gold Project, located 65 km northeast of Sudbury, Ontario.

ADDISON, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces that CECO management will participate at the following investor conferences:

License Expands Genprex's Portfolio of Oncology Gene Therapy Technologies AUSTIN, Texas , May 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it has entered into an exclusive patent license agreement with UTHealth Houston granting Genprex exclusivity and commercial rights relating to its lead drug candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid) for the potential treatment of glioblastoma. The subject patent is co-owned by Genprex and UTHealth Houston, and the license provides Genprex with patent exclusivity.

FX Edition Adds 18-inch Gloss White-Finished Alloy Wheels, Rear Wing and Sport Touring Seats with Orange Stitching Available in Ice Cap, Inferno and Blue Crush Metallic Expected to Arrive at Toyota Dealerships Fall 2025 PLANO, Texas , May 6, 2025 /PRNewswire/ -- For the 2026 model year, the Corolla Hatchback welcomes the FX edition into the fold, igniting the spirit of the legendary FX16. This special edition masterfully blends nostalgic charm with contemporary dynamism, injecting a dose of bold athleticism into the already spirited Corolla Hatchback.

Conference call and webcast to take place on Wednesday, May 14, 2025, at 4:30 p.m. ET SAN DIEGO and CALGARY, AB , May 6, 2025 Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Wednesday, May 14, 2025, at 4:30 p.m.

DUBLIN, Ireland and CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its first quarter 2025 financial results before the open of the U.S. financial markets on Tuesday, May 13, 2025. Management will host a conference call at 8:30 a.m.

TORONTO and GLIL YAM, Israel , May 6, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens. The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community.

BURLINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the first quarter 2025 and provide business updates on Tuesday, May 13, 2025, at 4:30 p.m.

BARCELONA, Spain , May 6, 2025 /PRNewswire/ -- Freightos Limited (NASDAQ: CRGO), the leading, vendor-neutral booking and payment platform for the international freight industry, will report its Q1 2025 financial results before market open on Tuesday, May 20, 2025. Freightos' management will host a webcast and conference call to discuss the results that day at 8:30 a.m.

First quarter 2025 RevPAR 1 increased 4.1 percent worldwide, with 3.3 percent growth in the U.S. & Canada and 5.9 percent growth in international markets First quarter reported diluted EPS totaled $2.39 and adjusted diluted EPS totaled $2.32 First quarter reported net income totaled $665 million and adjusted net income totaled $645 million First quarter adjusted EBITDA totaled $1,217 million The company added roughly 12,200 net rooms during the quarter and net rooms grew 4.6% from the end of the first quarter of 2024 At the end of the quarter, Marriott's worldwide development pipeline totaled approximately 3,800 properties and over …

Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses CONSHOHOCKEN, Pa. , May 6, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (Nasdaq: HLNE) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors.

Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery Stable U.S. same market treatment development despite impact from a severe flu season FME25 savings of EUR 68 million contributed to earnings Operating income2 grew 11% at constant currency resulting in margin expansion Reported operating income grew by 35% and reported net income3 by 113% Net leverage ratio further improved to 2.8x and FY 2025 outlook confirmed BAD HOMBURG, Germany , May 6, 2025 /PRNewswire/ -- "The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing …